New therapeutic strategies for lung disease

Brinkert, K., Hedtfeld, S., Burhop, A., Gastmeier, R., Gad, P., Wedekind, D., Kloth, C., Rothschuh, J., Lachmann, N., Hetzel, M., Jirmo, A.C., Lopez-Rodriguez, E., Brandenberger, C., Hansen, G., Schambach, A., Ackermann, M., Tümmler, B., Munder, A.: Mol Ther. 2021;29(3):1324-34. To access the full article, click here:

Lopez-Rodriguez, E., Gay-Jordi, G., Knudsen, L., Ochs, M., Serrano-Mollar, A.: Front Med. 2021;8:640020. To access the full article, click here: Idiopathic pulmonary fibrosis (IPF) is a progressively and ultimately fatal lung disease. Previously it has been shown that intratracheal administration of alveolar epithelial type II cells (AE2C) in

Hetzel, M., Lopez-Rodriguez, E., Mucci, A., Nguyen, A.H.H., Suzuki, T., Shima, K., Buchegger, T., Dettmer, S., Rodt, T., Bankstahl, J.P., Malik, P., Knudsen, L., Schambach, A., Hansen, G., Trapnell, B.C., Lachmann, N., Moritz, T.: Haematologica. 2020;105(4):1147-57. To access the full article, click here:

Beneke, V., Küster, F., Neehus, A.L., Hesse, C., Lopez-Rodriguez, E., Haake, K., Rafiei Hashtchin, A., Schott, J.W., Walter, D., Braun, A., Wolkers, W.F., Ackermann, M., Lachmann, N.: Sci Rep. 2018;8(1):16281. To access the full article, click here: Macrophages are key cells of the innate

Mucci, A., Lopez-Rodriguez, E., Hetzel, M., Liu, S., Suzuki, T., Happle, C., Ackermann, M., Kempf, H., Hillje, R., Kunkiel, J., Janosz, E., Brennig, S., Glage, S., Bankstahl, J.P., Dettmer, S., Rodt, T., Gohring, G., Trapnell, B., Hansen, G., Trapnell, C., Knudsen, L., Lachmann, N., Moritz, T.: Stem Cell Reports.

Steffen, L., Ruppert, C., Hoymann, H.G., Funke, M., Ebener, S., Kloth, C., Mühlfeld, C., Ochs, M., Knudsen, L., Lopez-Rodriguez, E.: Am J Physiol-Lung C. 2017;313(2):L313-27. To access the full article, click here: Bleomycin-induced lung injury leads to surfactant dysfunction and permanent loss of alveoli due to